Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development. | Biosci Rep | 2020 | 32420585 | PubTator, text mining | PubMed |
| Stimulation strength controls the rate of initiation but not the molecular organisation of TCR-induced signalling. | Elife | 2020 | 32412411 | PubTator, text mining | PubMed |
| Rheb1 protects against cisplatin-induced tubular cell death and acute kidney injury via maintaining mitochondrial homeostasis. | Cell Death Dis | 2020 | 32404875 | PubTator, text mining | PubMed |
| Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions. | Cell Rep | 2020 | 32402279 | PubTator, text mining | PubMed |
| Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis. | Cancer Res | 2020 | 32393662 | PubTator, text mining | PubMed |
| Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells. | Oncotarget | 2020 | 32391118 | PubTator, text mining | PubMed |
| Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition. | J Invest Dermatol | 2020 | 32389536 | PubTator, text mining | PubMed |
| BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways. | Aging (Albany NY) | 2020 | 32388500 | PubTator, text mining | PubMed |
| The Cytocidal Spectrum of Bacillus thuringiensis Toxins: From Insects to Human Cancer Cells. | Toxins (Basel) | 2020 | 32384723 | PubTator, text mining | PubMed |
| Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease. | Nat Commun | 2020 | 32382059 | PubTator, text mining | PubMed |
| Systems approach to rational combination therapy: PARP inhibitors. | Biochem Soc Trans | 2020 | 32379297 | PubTator, text mining | PubMed |
| FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer. | Mol Cancer Ther | 2020 | 32371583 | PubTator, text mining | PubMed |
| Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis. | J Cancer | 2020 | 32368287 | PubTator, text mining | PubMed |
| Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis. | Onco Targets Ther | 2020 | 32368080 | PubTator, text mining | PubMed |
| Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma. | Endocr Pathol | 2020 | 32367334 | PubTator, text mining | PubMed |
| Apoptosis Activation in Thyroid Cancer Cells by Jatrorrhizine-Platinum(II) Complex via Downregulation of PI3K/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. | Med Sci Monit | 2020 | 32341329 | PubTator, text mining | PubMed |
| Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma Via Oxidative Stress and Iron-Sulfur Cluster Biogenesis Deficit. | Antioxid Redox Signal | 2020 | 32336105 | PubTator, text mining | PubMed |
| Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression. | Front Immunol | 2020 | 32328063 | PubTator, text mining | PubMed |
| Emerging role of PTEN loss in evasion of the immune response to tumours. | Br J Cancer | 2020 | 32327707 | PubTator, text mining | PubMed |
| Ecotype differences in aggression, neural activity and behaviorally relevant gene expression in cichlid fish. | Genes Brain Behav | 2020 | 32323443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=46